Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...
14hon MSN
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
The justices are considering an effort challenging longstanding case law blocking the state’s ability to probe inflated drug ...
Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Eli Lilly is pouring another $4.5 billion into ... drug development a few miles from its Indianapolis headquarters. The company said its Lilly Medicine Foundry will allow it to both research ...
Scheduled to open in late 2027, the site will combine research and manufacturing and increase the company's investment in the ...
AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular disease drug candidate. The deal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback